Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Development and validation of an ECM-related prognostic signature to predict the immune landscape of human hepatocellular carcinoma

Fig. 3

Identification of Prognosis-Related ECMrlncRNAs and Signature Development. Heatmap visualizing the expression levels of MKLN1-AS and AL031985.3 in the total LIHC cohort (A). PCA displays the distribution of different-risk patients and differences in survival status (alive or dead) (B and C). Survival curves revealed the prognostic differences between the high- and low-risk HCC groups (D)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us